← Back to catalogue

cobas Factor II and Factor V Test

FDA UDI

Class II (US FDA UDI)

by Roche Molecular Systems, Inc.

Identity

Trade Name
cobas Factor II and Factor V Test FDA UDI
Generic Name
Inherited thrombophilia IVD, kit, nucleic acid technique (NAT) FDA UDI
Model / Reference
07948352190 FDA UDI

Identifiers

Catalog Number
07948352190 FDA UDI
Primary DI / UDI-DI
00875197005998 FDA UDI
510(k) Number
K172913 FDA UDI
FDA Product Code
NPR FDA UDI
NPQ FDA UDI
GMDN Term
Inherited thrombophilia IVD, kit, nucleic acid technique (NAT) FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
864.7280 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Inherited thrombophilia IVD, kit, nucleic acid technique (NAT)Coagulation factor II (prothrombin) mutation IVD, kit, nucleic acid technique (NAT)

cobas Factor II and Factor V Test by Roche Molecular Systems, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Coagulation factor II (prothrombin) mutation IVD, kit, nucleic acid technique (NAT).

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI d8becc8c-fb0b-40ea-99c8-af292e327364 34 fields · synced Jun 9, 2026